FDA Approved: CREON — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CREON (pancrelipase) from AbbVie, updating its labeling/indication as part of a supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• Creon (pancrelipase)

Snippet

SUPPL AP for CREON (PANCRELIPASE)